Odds of Advanced Liver Fibrosis Up With Episodic Heavy Drinking

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Amazon Big Spring Sale - Up to 40% off

Medically reviewed by Carmen Pope, BPharm. Last updated on April 3, 2026.

via HealthDay

FRIDAY, April 3, 2026 -- Episodic heavy drinking is prevalent in metabolic dysfunction-associated steatotic liver disease (MASLD) and is associated with significantly higher odds of advanced liver fibrosis, according to a study published online April 2 in Clinical Gastroenterology and Hepatology.

Using data from the 2017 to 2023 National Health and Nutrition Examination Survey, Yinan Su, from the University of Southern California Keck School of Medicine in Los Angeles, and colleagues examined adults with vibration-controlled transient elastography data to assess episodic heavy drinking among steatotic liver disease (SLD) subcategories and its association with liver fibrosis.

Overall, 4,571 of the 8,006 individuals had SLD: 3,969; 373; and 144 had MASLD, MASLD with increased alcohol (MetALD), and alcohol-associated liver disease (ALD), respectively. The researchers found that 15.9 percent of those with MASLD had episodic heavy drinking, which was associated with significant and advanced liver fibrosis (adjusted odds ratios, 1.69 and 2.76, respectively). The adjusted weighted prevalence of significant liver fibrosis was higher among MASLD with versus without episodic heavy drinking (23.6 versus 15.6 percent). The weighted prevalence of MASLD was decreased (48.0 to 40.4 percent), while the weighted prevalence of MetALD was increased (5.3 to 12.9 percent) and ALD was similar (1.9 to 2.1 percent), with subgroup prevalence using consensus nomenclature versus including episodic heavy drinking as MetALD or ALD.

"Our research suggests that the public needs to be much more aware of the danger of occasional heavy drinking and should avoid it even if they drink moderately the rest of the time," principal author Brian P. Lee, M.D., also from the Keck School of Medicine, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-04 01:41

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords